Platelet dense granules: Structure, function and implications for haemostasis

Thrombosis Research

Volumn 95, Issue 1, 1999, Pages 1-18

  McNicol, Archibald ^a   Israels, Sara J ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Dense granule; Exocytosis; Granule contents; Granule deficiency; Membrane composition

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CHEDIAK HIGASHI SYNDROME; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXOCYTOSIS; HEMOSTASIS; LEUKEMIA; LYSOSOME; NONHUMAN; OCULAR ALBINISM; PRIORITY JOURNAL; SECRETORY GRANULE; SHORT SURVEY; STORAGE DISEASE; STRUCTURE ANALYSIS; THROMBOCYTE; WISKOTT ALDRICH SYNDROME;

ANIMALS; BLOOD PLATELETS; CYTOPLASMIC GRANULES; HUMANS; PLATELET ACTIVATION;

EID: 0033165875     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00015-8     Document Type: Short Survey

References (153)

1. Gerrard J.M. Platelet aggregation. Cellular regulation and physiologic role Hosp Pract. 23:1998;89-108.
2. Bizzozero G. Über einen neuen Formbestandteil des Blutes und dessen Rolle bei der Thrombose und der Blutgerinnung. Virchows Arch Pathol Anat Physiol Klin Med. 90:1881;216-284.
3. Hayem G. Sur le mechanisme de'arret des hemorrhagies. C R Acad Sci. 95:1878;18-20.
4. Page C.P. The involvement of platelets in non-thrombotic processes. Trends Pharmacol Sci. 9:1988;66-71.
5. Harrison P., Cramer E.M. Platelet alpha-granules. Blood Rev. 7:1993;52-62.
6. van Oost B.A. Acid hydrolase secretion. Holmsen H. Platelet Responses and Metabolism II. 1986;163-191 CRC Press Inc, Boca Raton, FL.
7. White J.G. The dense bodies of human platelets. Inherent electron opacity of the serotonin storage particles Blood. 33:1969;598-606.
8. Israels S.J., McNicol A., Robertson C., Gerrard J.M. Platelet storage pool deficiency. Diagnosis in patients with prolonged bleeding times and normal platelet aggregation Br J Haematol. 75:1990;118-121.
9. Holmsen H., Weiss H.J. Secretable storage pools in platelets. Ann Rev Med. 30:1979;119-134.
10. Da Prada M., Richards J.G., Kettler R. Amine storage vesicles in platelets. Gordon J.L. Platelets in Biology and Pathology. 1981;107-146 Elsevier/North Holland, Amsterdam.
11. Meyers K.M. Pathobiology of animal platelets. Adv Vet Sci Comp Med. 30:1985;131-165.
12. Fukami M.H., Holmsen H., Ugurbil K. Histamine uptake in pig platelets and isolated dense granules. Biochem Pharmacol. 33:1984;3869-3874.
13. Kunapuli S.P. Multiple P2 receptor subtypes on platelets. A new interpretation of their function Trend Pharmacol Sci. 19:1998;391-394.
14. MacKenzie A.B., Mahaut-Smith M.P., Sage S.O. Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets. J Biol Chem. 271:1996;2879-2881.
15. 2 receptors. Multiple sites and multiple receptors Trends Pharmacol Sci. 19:1998;99-107.
16. 2 receptor sites on human blood platelets. Biochem Pharmacol. 33:1984;2807-2811.
17. De Clerck F. Blood platelets in human essential hypertension. Agents Actions. 18:1986;563-580.
18. Dean G.E., Fishkes H., Nelson P.J., Rudnick G. The hydrogen ion-pumping adenosine triphosphatase of platelet dense granule membrane. Differences from F1F0- and phosphoenzyme-type ATPases. J Biol Chem. 259:1984;9569-9574.
19. Carty S.E., Johnson R.G., Scarpa A. Serotonin transport in isolated platelet granules. Coupling to the electrochemical proton gradient. J Biol Chem. 256:1981;11244-11250.
20. Fishkes H., Rudnick G. Bioenergetics of serotonin transport by membrane vesicles derived from platelet dense granules. J Biol Chem. 257:1982;5671-5677.
21. Rudnick G., Fishkes H., Nelson P.J., Schuldiner S. Evidence for two distinct serotonin transport systems in platelets. J Biol Chem. 255:1980;3638-3641.
22. Lesch K.P., Wolozin B.L., Murphy D.L., Reiderer P.J. Primary structure of the human platelet serotonin uptake site. Identity with the brain serotonin transporter J Neurochem. 60:1983;2319-2322.
23. Rendu F., Lebret M., Danielian S., Fagard R., Levy-Toledano S., Fischer S. High pp60c-src level in human platelet dense bodies. Blood. 73:1989;1545-1551.
24. Ferrell J.E. Jr., Noble J.A., Martin G.S., Jacques Y.V., Bainton D.F. Intracellular localization of pp60c-src in human platelets. Oncogene. 5:1990;1033-1036.
25. c-src. Thromb Res. 65:1992;77-83.
26. Bhullar R.P., Haslam R.J. Gn-proteins are distinct from ras p21 and other known low molecular mass GTP-binding proteins in the platelet. FEBS Lett. 237:1988;168-172.
27. Karniguian A., Zahraoui A., Tavitian A. Identification of small GTP-binding rab proteins in human platelets. Thrombin-induced phosphorylation of rab3B, rab6, and rab8 proteins Proc Natl Acad Sci USA. 90:1993;7647-7651.
28. Berger G., Quarck R., Tenza D., Levy-Toledano S., de Gunzburg J., Cramer E.M. Ultrastructural localization of the small GTP-binding protein Rap1 in human platelets and megakaryocytes. Br J Haematol. 88:1994;372-382.
29. Nagata K., Nozawa Y. A low M(r) GTP-binding protein, Rap1, in human platelets. Localization, translocation and phosphorylation by cyclic AMP-dependent protein kinase Br J Haematol. 90:1995;180-186.
30. Jilkina O., Bhullar R.P. Generation of antibodies specific for the RalA and RalB GTP-binding proteins and determination of their concentration and distribution in human platelets. Biochim Biophys Acta. 1314:1996;157-166.
31. Mark B.L., Jilkina O., Bhullar R.P. Association of Ral GTP-binding protein with human platelet dense granules. Biochem Biophys Res Commun. 225:1996;40-46.
32. Youssefian T., Masse J.M., Rendu F., Guichard J., Cramer E.M. Platelet and megakaryocyte dense granules contain glycoproteins Ib and IIb-IIIa. Blood. 89:1997;4047-4057.
33. Berndt M.C., Gregory C., Kabral A., Zola H., Fournier D., Castaldi P.A. Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. Eur J Biochem. 151:1985;637-649.
34. Andrews R.K., Fox J.E. Identification of a region in the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX complex that binds to purified actin-binding protein. J Biol Chem. 267:1992;18605-18611.
35. Shattil S.J. Function and regulation of the beta 3 integrins in hemostasis and vascular biology. Thromb Haemost. 74:1995;149-155.
36. Shattil S.J., Kashiwagi H., Pampori N. Integrin signaling. The platelet paradigm Blood. 91:1998;2645-2657.
37. Furman M.I., Gardner T.M., Goldschmidt-Clermont P.J. Mechanisms of cytoskeletal reorganization during platelet activation. Thromb Haemost. 70:1993;229-232.
38. Israels S.J., Gerrard J.M., Jacques Y.V., McNicol A., Cham B., Nishibori M., Bainton D.F. Platelet dense granule membranes contain both granulophysin and P-selectin (GMP-140). Blood. 80:1992;143-152.
39. Stenberg P.E., McEver R.P., Shuman M.A., Jacques Y.V., Bainton D.F. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 101:1985;880-886.
40. McEver R.P. GMP-140. A receptor for neutrophils and monocytes on activated platelets and endothelium J Cell Biochem. 45:1991;156-161.
41. Furie B., Furie B.C. Leukocyte crosstalk at the vascular wall. Thromb Haemost. 78:1997;306-309.
42. Parmentier S., McGregor L., Catimel B., Leung L.L., McGregor J.L. Inhibition of platelet functions by a monoclonal antibody (LYP20) directed against a granule membrane glycoprotein (GMP-140/PADGEM). Blood. 77:1991;1734-1739.
43. Maecker H.T., Todd S.C., Levy S. The tetraspanin superfamily. Molecular facilitators FASEB J. 11:1997;428-442.
44. Metzelaar M.J., Nieuwenhuis H.K. Identity of Pltgp40 and lysomal integral membrane protein-CD63. Blood. 78:1991;534-535.
45. Nishibori M., Cham B., McNicol A., Shalev A., Jain N., Gerrard J.M. The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin. J Clin Invest. 91:1993;1775-1782.
46. Metzelaar M.J., Wijngaard P.L., Peters P.J., Sixma J.J., Nieuwenhuis H.K., Clevers H.C. CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem. 266:1991;3239-3245.
47. Azorsa D.O., Hyman J.A., Hildreth J.E. CD63/Pltgp40, a platelet activation antigen identical to the stage-specific, melanoma-associated antigen ME491. Blood. 78:1991;280-284.
48. Febbraio M., Silverstein R.L. Identification and characterization of LAMP-1 as an activation-dependent platelet surface glycoprotein. J Biol Chem. 265:1990;18531-18537.
49. Silverstein R.L., Febbraio M. Identification of lysosome-associated membrane protein-2 as an activation-dependent platelet surface glycoprotein. Blood. 80:1992;1470-1475.
50. Israels S.J., McMillan E.M., Robertson C., Singhory S., McNicol A. The lysosomal granule membrane protein, LAMP-2, is also present in platelet dense granule membranes. Thromb Haemost. 75:1996;623-629.
51. Novak E.K., Hui S.W., Swank R.T. The mouse pale ear pigment mutant as a possible animal model for human platelet storage pool deficiency. Blood. 57:1981;38-43.
52. Novak E.K., Hui S.W., Swank R.T. Platelet storage pool deficiency in mouse pigment mutations associated with seven distinct genetic loci. Blood. 63:1984;536-544.
53. Fukuda M. Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem. 266:1991;21327-21330.
54. Kannan K., Stewart R.M., Bounds W., Carlsson S.R., Fukuda M., Betzing K.W., Holcombe R.F. Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. Cell Immunol. 171:1996;10-19.
55. Oh J., Bailin T., Fukai K., Feng G.H., Ho L., Mao J.I., Frenk E., Tamura N., Spritz R.A. Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles. Nat Genet. 14:1996;300-306.
56. Ramsay M. Protein trafficking violations. Nat Genet. 14:1996;242-245.
57. Nagle D.L., Karim M.A., Woolf E.A., Holmgren L., Bork P., Misumi D.J., McGrail S.H., Dussault B.J. Jr., Perou C.M., Boissy R.E., Duyk G.M., Spritz R.A., Moore K.J. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet. 14:1996;307-311.
58. Rand M.L., Perry D.W., Packham M.A., Gemmell C.H., Yeo E.L., Kinlough-Rathbone R.L. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN. Direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression Am J Hematol. 52:1996;288-294.
59. Nozawa Y., Banno Y., Nagata K. Regulation of phosphoinositide-specific phospholipase C activity in human platelets. Adv Exp Med Biol. 344:1993;37-47.
60. Brass L.F., Manning D.R., Cichowski K., Abrams C.S. Signaling through G proteins in platelets. To the integrins and beyond Thromb Haemost. 78:1997;581-589.
61. Gerrard J.M., Beattie L.L., Park J., Israels S.J., McNicol A., Lint D., Cragoe E.J. Jr. A role for protein kinase C in the membrane fusion necessary for platelet granule secretion. Blood. 74:1989;2405-2413.
62. Gerrard J.M., McNicol A., Saxena S.P. Protein kinase C, membrane fusion and platelet granule secretion. Biochem Soc Trans. 21:1993;289-293.
63. Morimoto T., Ogihara S. ATP is required in platelet serotonin exocytosis for protein phosphorylation and priming of secretory vesicles docked on the plasma membrane. J Cell Sci. 109:1996;113-118.
64. Augustine G.J., Burns M.E., DeBello W.M., Pettit D.L., Schweizer F.E. Exocytosis. Proteins and perturbations Annu Rev Pharmacol Toxicol. 36:1996;659-701.
65. Lemons P.P., Chen D., Bernstein A.M., Bennett M.K., Whiteheart S.W. Regulated secretion in platelets. Identification of elements of the platelet exocytosis machinery Blood. 90:1997;1490-1500.
66. Vitale M.L., Seward E.P., Trifaro J.M. Chromaffin cell cortical actin network dynamics control the size of the release-ready vesicle pool and the initial rate of exocytosis. Neuron. 14:1995;353-363.
67. Calakos N., Scheller R.H. Vesicle-associated membrane protein and synaptophysin are associated on the synaptic vesicle. J Biol Chem. 269:1994;24534-24537.
68. Südhof T.C. The synaptic vesicle cycle. A cascade of protein-protein interactions Nature. 375:1995;645-653.
69. Bahler M., Cesura A.M., Fischer G., Kuhn H., Klein R.L., Da Prada M. Serotonin organelles of rabbit platelets contain synaptophysin. Eur J Biochem. 194:1990;825-829.
70. Gerrard J.M., Lint D., Sims P.J., Wiedmer T., Fugate R.D., McMillan E., Robertson C., Israels S.J. Identification of a platelet dense granule membrane protein that is deficient in a patient with the Hermansky-Pudlak syndrome. Blood. 77:1991;101-112.
71. Weiss H.J., Lages B., Vicic W., Tsung L.Y., White J.G. Heterogeneous abnormalities of platelet dense granule ultrasctructure in 20 patients with congenital storage pool deficiency. Br J Haematol. 83:1993;282-295.
72. Holmsen H., Weiss H.J. Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia - "Storage Pool Disease" Blood. 39:1972;197-209.
73. 2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency - a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor. Thromb Haemost. 77:1997;376-382.
74. White J.G., Gerrard J.M. Ultrastructural features of abnormal blood platelets. Am J Patholol. 83:1976;590-632.
75. Nieuwenhuis H.K., Akkerman J.N., Sixma J.J. Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency. studies on one hundred six patients Blood. 70:1987;620-623.
76. Higashi T., Isomoto A., Tyuma I., Kakishita E., Uomoto M., Nagi K. Quantitative and continuous analysis of ATP release from blood platelets with firefly luciferase luminescence. Thromb Haemost. 53:1985;65-69.
77. Witkop C.J., Krumwiede M., Sedano H., White J.G. Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome. Am J Hematol. 26:1987;305-311.
78. Richards J.G., Da Prada M. Uranaffin reaction. A new cytochemical technique for the localization of adenine nucleotides in organelles storing biogenic amines J Histochem Cytochem. 25:1977;1322-1326.
79. 14C-5-HT and platelet density in Bernard-Soulier and Hermansky-Pudlak syndromes. Thromb Haemost. 42:1979;694-704.
80. Gordon N., Thom J., Cole C., Baker R. Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry. Br J Haematol. 89:1995;117-123.
81. Wall J.E., Buijs-Wilts M., Arnold J.T., Wang W., White M.M., Jennings L.K., Jackson C.W. A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents. Br J Haematol. 89:1995;380-385.
82. Weiss H.J., Lages B., Hoffmann T., Turitto V.T. Correction of the platelet adhesion defect in δ-storage pool deficiency at elevated hematocrit - possible role of adenosine diphosphate. Blood. 87:1996;4214-4222.
83. Weiss H.J., Lages B. Platelet prothrombinase activity and intracellular calcium responses with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity - a comparison with Scott Syndrome. Blood. 89:1997;1599-1611.
84. Weiss H.J., Witte L.D., Kaplan K.L., Lages B.A., Chernoff A., Nossel H.L., Goodman D.S., Baumgartner H.R. Heterogeneity in storage pool deficiency. studies on granule-bound substances in 18 patients including variants deficient in α-granules, platelet factor 4, β-thromboglobulin, and platelet-derived growth factor Blood. 54:1979;1296-1319.
85. Lages B., Shattil S.J., Bainton D.F., Weiss H.J. Decreased content and surface expression of alpha-granule membrane protein GMP-140 in one of two types of platelet alpha delta storage pool deficiency. J Clin Invest. 87:1991;919-929.
86. McNicol A., Israels S.J., Robertson C., Gerrard J.M. The empty sack syndrome. A platelet storage pool deficiency associated with empty dense granules Br J Haematol. 86:1994;574-582.
87. Lorez H.P., Richards J.G., Da Prada M., Picotti G.B., Pareti F.I., Capitanio A., Mannucci P.M. Storage pool disease. Comparative fluorescence microscopical, cytochemical and biochemical studies on amine-storing organelles of human blood platelets Br J Haematol. 43:1979;297-305.
88. Lages B., Holmsen H., Weiss H.J., Dangelmaier C. Thrombin and ionophore A23187-induced dense granule secretion in storage pool deficient platelets. Evidence for impaired nucleotide storage as the primary dense granule defect Blood. 61:1983;154-162.
89. White J.G., Smithson W.A., McCaffrey L.A., Rao G.H.R. Platelet hypercalcemia and giant dense bodies. A new familial disorder Blood. 68:1986;1312a.
90. Erickson R.P. Pigment, platelets and Hermansky-Pudlak in human and mouse. Proc Natl Acad Sci USA. 94:1997;8924-8925.
91. Swank R.T., Novak E.K., McGarry M.P., Rusiniak M.P., Feng L. Mouse models of Hermansky Pudlak Syndrome. A review Pigment Cell Res. 11:1998;60-80.
92. Hemansky F., Pudlak P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow. Report of two cases with histochemical studies Blood. 14:1959;162-169.
93. King R.A., Hearing V.J., Creel D.J., Oetting W.S. Albinism. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Disease, Vol. 3. 7th ed:1995;4353-4392 McGraw-Hill, New York.
94. Gahl W.A., Brantly M., Kaiser-Kupper M.I., Iwata F., Hazelwood S., Shotelersuk V., Duffy L.F., Kuehl E.M., Troendle J., Bernardini I. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Eng J Med. 338:1998;1258-1264.
95. Witkop C.J., Babcock M.N., Rao G.H.R. Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Assoc Med P R. 82:1990;333-339.
96. Fukai K., Oh J., Frenk E., Almodovar C., Spritz R.A. Linkage disequilibrium mapping of the gene for Hermansky-Pudlak syndrome to chromosome 10q23.1-q23.3. Hum Mol Genet. 4:1995;1665-1669.
97. Wildenberg S.C., Oetting W.S., Almodovar C., Krumwiede M., White J.G., King R.A. A gene causing Hermansky-Pudlak syndrome in a Puerto Rican population maps to chromosome 10q2. Am J Hum Genet. 57:1995;755-765.
98. Chediak M. Nouvelle anomalie leukocytaire de caractere constitutionnel et familiel Rev Haematol 1952;7:362-7.
99. Higashi O. Congenital giangantism of peroxidase granules. Tohoku J Exp Med. 59:1954;315-332.
100. Spritz R.A. Genetic defects in Chediak-Higashi syndrome and the beige mouse. J Clin Immunol. 18:1998;97-105.
101. Rubin C.M., Burke B.A., McKenna R.W., McClain K.L., White J.G., Nesbit M.E., Filipovich A.H. The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome? Cancer. 56:1985;524-530.
102. Virelizier J.L., Lagrue A., Durandy A., Arenzana F., Oury C., Griscelli C., Reinert P. Reversal of natural killer defect in a patient with Chediak-Higashi syndrome after bone marrow transplantation. Lancet. 306:1982;1055-1056.
103. Haddad E., Le Deist F., Blanche S., Benkerrou M., Rohlich P., Vilmer E., Griscelli C., Fischer A. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation. Blood. 85:1995;270-276.
104. Mottonen M., Lanning M., Saarinen U.M. Allogeneic bone marrow transplantation in Chediak-Higashi syndrome. Pediatr Hematol Oncol. 12:1995;55-59.
105. Boxer G.J., Holmsen H., Robkin L., Bang N.U., Boxer L.A., Baehner R.L. Abnormal platelet function in Chediak-Higashi syndrome. Br J Haematol. 35:1977;521-533.
106. Buchanan G.R., Handin R.I. Platelet function in the Chediak-Higashi syndrome. Blood. 47:1976;941-948.
107. Barrat F.J., Auloge L., Pastural E., Lagelouse R.D., Vilmer E., Cant A.J., Weissenbach J., Le Paslier D., Fischer A., de Sainte Basile G. Genetic and physical mapping of the Chediak-Higashi syndrome on chromosome 1q42-q43. Am J Hum Gen. 59:1996;625-633.
108. Barbosa M.D., Nguyen Q.A., Tchernev V.T., Ashley J.A., Detter J.C., Blaydes S.M., Brandt S.J., Chotai D., Hodgman C., Solari R.C., Lovett M., Kingsmore S.F. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature. 382:1996;262-265.
109. Perou C.M., Moore K.J., Nagle D.L., Misumi D.J., Woolf E.A., McGrail S.H., Holmgren L., Brody T.H., Dussault B.J. Jr., Monroe C.A., Duyk G.M., Pryor R.J., Li L., Justice M.J., Kaplan J. Identification of the murine beige gene by YAC complementation and positional cloning. Nat Genet. 13:1996;303-308.
110. Day J.H., Holmsen H. Plaletet adenine nucleotide "Storage Pool Deficiency" in thrombocytopenic absent radii syndrome. JAMA. 221:1972;1053-1054.
111. Grottum K.A., Horig T., Holmsen H. Wiskott-Aldrich syndrome. Qualitative platelet defects and short platelet survival Br J Haematol. 17:1969;373-387.
112. Semple J.W., Siminovitch K.A., Mody M., Milev Y., Lazarus A.H., Wright J.F., Freedman J. Flow cytometric analysis of platelets from children with the Wiskott-Aldrich syndrome reveals defects in platelet development, activation and structure. Br J Haematol. 97:1997;747-754.
113. Armitage J.O., Hoak J.C., Elliot T.E., Fry G.L. Syndrome of thrombocytopenia and absent radii. Qualitatively normal platelets with remission following splenectomy Scan J Haematol. 20:1978;25-28.
114. Gerrard J.M., Stoddard S.F., Shapiro R.S., Coccia P.F., Ramsay N.K., Nesbit M.E., Rao G.H., Krivit W., White J.M. Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukemia. Br J Haematol. 40:1978;597-607.
115. Gerrard J.M., Israels E.D., Bishop A.J., Schroeder M.L., Beattie L.L., McNicol A., Israels S.J., Walz D., Greenberg A.H., Ray M., Israels L.G. Inherited platelet-storage pool deficiency associated with a high incidence of acute myeloid leukaemia. Br J Haematol. 79:1991;246-255.
116. Luddy R.E., Champion L.A., Schwartz A.D. A fatal myeloproliferative syndrome in a family with thrombocytopenia and platelet dysfunction. Cancer. 41:1978;1959-1963.
117. Dowton S.B., Beardsley D., Jamison D., Blottner S., Li F.P. Studies of a familial platelet disorder. Blood. 65:1985;557-563.
118. Novak E.K., Sweet H.O., Prochazka M., Parentis M., Soble R., Reddington M., Cairo A., Swank R.T. Cocoa. A new mouse model for platelet storage pool deficiency Br J Haematol. 69:1988;371-378.
119. Swank R.T., Reddington M., Howlett O., Novak E.K. Platelet storage pool deficiency associated with inherited abnormalities of the inner ear in the mouse pigment mutants muted and mocha. Blood. 78:1991;2036-2044.
120. Swank R.T., Sweet H.O., Davisson M.T., Reddington M., Novak E.K. Sandy. A new mouse model for platelet storage pool deficiency Genet Res. 58:1991;51-62.
121. Gardner J.M., Wildenberg S.C., Keiper N.M., Novak E.K., Rusiniak M.E., Swank R.T., Puri N., Finger J.N., Hagiwara N., Lehman A.L., Gales T.L., Bayer M.E., King R.A., Brilliant M.H. The mouse pale ear (ep) mutation is the homologue of human Hermansky-Pudlak syndrome. Proc Natl Acad Sci USA. 94:1997;9238-9243.
122. Sviderskaya E.V., Novak E.K., Swank R.T., Bennett D.C. The murine misty mutation. Phenotypic effects on melanocytes, platelets and brown fat Genetics. 148:1998;381-390.
123. Meyers K.M., Holmsen H., Seachord C.L., Hopkins G.E., Borchard R.E., Padgett G.A. Storage pool deficiency in platelets from Chediak-Higashi cattle. Am J Physiol. 237:1979;R239-R248.
124. Meyers K.M., Hopkins G., Holmsen H., Benson K., Prieur D.J. Ultrastructure of resting and activated storage pool deficient platelets from animals with the Chediak-Higashi syndrome. Am J Pathol. 106:1982;364-377.
125. Meyers K.M., Seachord C.L., Benson K., Fukami M., Holmsen H. Serotonin accumulation in granules of storage pool-deficient platelets of Chediak-Higashi cattle. Am J Physiol. 245:1983;H150-H158.
126. Meyers K.M., Seachord C.L., Holmsen H., Prieur D.J. Evaluation of the platelet storage pool deficiency in the feline counterpart of the Chediak-Higashi syndrome. Am J Hematol. 11:1981;241-253.
127. Meyers K.M., Holmsen H., Seachord C.L., Hopkins G., Gorham J. Characterization of platelets from normal mink and mink with the Chediak-Higashi syndrome. Am J Hematol. 7:1979;137-146.
128. Daniels T.M., Fass D.N., White J.G., Bowie E.J. Platelet storage pool deficiency in pigs. Blood. 67:1986;1043-1047.
129. Radvanyi-Hofmann H., Roussi J., Launay J.M., Bonneau M., Prevost M.C., Vargaftig B., Drouet L. Characterization of a thrombopathy (type delta storage pool disease) affecting a pig colony. Nouv Rev Fr Hematol. 34:1992;133-140.
130. Witkop C.J., Bowie E.J.W., Krumwiede M.D., Swanson J.L., Plumhoff E.A., White J.G. Synergistic effect of storage pool deficient platelets and low plasma von Willebrand factor on the severity of hemorhagic diathesis in Hermansky Pudlak Syndrome. Am J Hematol. 44:1993;256-259.
131. Callan M.B., Bennett J.S., Phillips D.K., Haskins M.E., Hayden J.E., Anderson J.G., Giger U. Inherited platelet delta-storage pool disease in dogs causing severe bleeding. An animal model for a specific ADP deficiency Thromb Haemost. 74:1995;949-953.
132. Pareti F.I., Capitanio A., Mannucci P.M. Acquired storage pool disease in platelets during disseminated intravascular coagulation. Blood. 48:1976;511-515.
133. Khurana M.S., Lian E.C., Harkness D.R. "Storage Pool Disease" of platelets. Association with multiple congenital cavernous hemangiomas. JAMA. 244:1980;169-171.
134. Rumbaut R.E., Kroll M.H., Gyorkey F., Schafer A.I. Acquired platelet storage pool deficiency due to severe valvular disease corrected by prosthetic valve replacement. Am J Hematol. 45:1994;272-273.
135. Konijnenberg A., Stokkers E.W., van der Post J.A., Schaap M.C., Boer K., Bleker O.P., Sturk A. Extensive platelet activation in preeclampsia compared with normal pregnancy. enhanced expression of cell adhesion molecules Am J Obstet Gyncol. 176:1997;461-469.
136. Janes S.L., Kyle P.M., Redman C., Goodall A.H. Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thromb Haemost. 74:1995;1059-1063.
137. Tschoepe D., Driesch E., Schwippert B., Nieuwenhuis H.K., Gries F.A. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalised by near normoglycemia. Diabetes. 44:1995;890-894.
138. Murakami T., Komiyama Y., Masuda M., Kido H., Nomura S., Fukuhara S., Karakawa M., Iwasaka T., Takashi H. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease. Eur J Clin Invest. 26:1996;996-1003.
139. Gutensohn K., Beythien C., Bau J., Meinertz T., Kuehnl P. Flow cytometric analysis of coronary stent-unduced alterations of platelet antigens in an in vitro model. Thromb Res. 86:1997;49-56.
140. Abrams C., Shattil S.J. Immunological detection of activated platelets in clinical disorders. Thromb Haemost. 65:1991;467-473.
141. Pareti F.I., Gugliotti L., Mannucci L., Guarini A., Mannucci P.M. Biochemical and metabolic aspects of platelets dysfunction in chronic myeloproliferative disorders. Thromb Haemost. 47:1982;84-89.
142. Yamamoto K., Sekiguchi E., Takatani O. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders. Thromb Haemost. 52:1984;292-296.
143. Malpass T.W., Savage B., Hanson S.R., Slichter S.J., Harker L.A. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders. J Lab Clin Med. 103:1984;894-904.
144. Mohri H. Acquired Won Willebrand disease and storage pool disease in chronic myelocytic leukemia. Am J Hematol. 22:1986;391-401.
145. Gerrard J.M., McNicol A. Platelet storage pool deficiency, leukemia, and myelodysplastic syndromes. Leuk Lymphoma. 8:1992;277-281.
146. Carr M.E. Jr., Hines S., Carr S.L., Todd W.M., Taylor T.L., Mohanty L. Storage pool disease in chronic lymphocytic leukemia. Abnormal aggregation and secretion without bleeding Am J Med Sci. 313:1997;176-181.
147. Wehmeier A., Südhoff T., Meierkord F. Relationship of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders. Semin Thromb Hemost. 23:1997;391-402.
148. Kobrinsky N.L., Israels E.D., Gerrard J.M., Cheang M.S., Watson C.M., Bishop A.J., Schroeder M.L. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet. i:1984;1145-1148.
149. Neuwenhuis H.K., Sixma J.J. 1-Desamino-8-D-arginine vasopressin (Desmopressin) shortens the bleeding time in storage pool deficiency. Ann Intern Med. 108:1988;65-67.
150. Schulman S., Johnson H., Egberg N., Blombäck M. DDAVP-induced correction of prolonged bleeding time in patients with congenital platelet function defects. Thromb Res. 45:1987;165-174.
151. DiMichelle D.M., Hathaway W.E. Use of DDAVP in inherited and acquired platelet dysfunction. Am J Hematol. 33:1990;39-45.
152. Manucci P.M. Desmopressin (DDAVP) in the treatment of bleeding disorders the first 20 years. Blood. 90:1997;2515-2521.
153. Rao A.K., Ghosh S., Sun L., Yang X., Disa J., Pickens P., Polansky M. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial. Thromb Haemost. 74:1995;1071-1078.